Third Rock Ventures GP IV, L.P. sold $7.7M of Tango Therapeutics (TNGX)

Executed Aug 19 2025, disclosed Aug 21 2025, 2 days later.

Value, as filed

$7.7M

1,100,000 sh × $7.01

Executed

Aug 19 2025

the trade date, as filed

Disclosed

Aug 21 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

TP Third Rock Ventures GP IV, L.P. 10% owner profile →

Third Rock Ventures GP IV, L.P. (10% owner) filed 2 Form 4 reports as a reporting entity in the past 24 months (0 purchases, 2 sales), most often in Tango Therapeutics, Inc. (TNGX). The largest single filing was $7.7M of TNGX (1,100,000 sh × $7.01, as filed), executed Aug 19 2025.

The name

TNGX

Tango Therapeutics, Inc. TNGX · Healthcare · 23 filings in 24 months ticker →

Healthcare · Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations wi…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Third Rock Ventures GP IV, L.P. in TNGX

TNGXSALE Tango Therapeutics, Inc. $2.1M
302,194 sh × $7.00
Exec Aug 22 2025
Filed Aug 26 2025 · 5:30 PM ET